Although higher delay discounting rates have been linked to cigarette smoking, little is
known about the stability of delay discounting, whether delay discounting promotes smoking …

Background Substantial variability exists in therapeutic response and adverse effects with
pharmacotherapies for tobacco dependence. Biomarkers to optimise treatment choice for …

Background Nicotine is metabolized to cotinine, and cotinine is metabolized to 3′‐hydroxycotinine
(3‐HC) by the liver enzyme cytochrome P450 (CYP) 2A6. More rapid metabolism of …

Craving is a hallmark of drug dependence, including dependence on nicotine. Many studies
have examined the neural substrates of cravings elicited by smoking-related cues. Less is …

The tumor microenvironment (TME) plays a major role in the pathogenesis of multiple cancer
types, including upper-gastrointestinal (GI) cancers that currently lack effective therapeutic …

Hypoxia is known to be an important prognostic marker in many human cancers. We report
the use of two oxygen measurement techniques in human brain tumors and compare these …

Transdermal nicotine is widely used for smoking cessation, but only ~20% of smokers quit
successfully with this medication. Interindividual variability in nicotine metabolism rate may …

Notch1 transactivates Notch3 to drive terminal differentiation in stratified squamous epithelia.
Notch1 and other Notch receptor paralogs cooperate to act as a tumor suppressor in …

Blood tests to detect circulating tumor cells (CTC) offer great potential to monitor disease
status, gauge prognosis, and guide treatment decisions for patients with cancer. For patients …

We explored the clinical and pathological impact of epidermal growth factor receptor (EGFR)
extracellular domain missense mutations. Retrospective assessment of 260 de novo …